Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2017 2
2018 1
2019 1
2020 1
2021 1
2022 7
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisons.
Xu D, Yu F, Guo T, Zhou Y, Zhang J, Li Y, Jiang S, Mao J, Yang X, Chu L, Chu X, Wang S, Ni J, Zhu Z. Xu D, et al. Br J Radiol. 2022 Aug 1;95(1136):20220035. doi: 10.1259/bjr.20220035. Epub 2022 Jun 9. Br J Radiol. 2022. PMID: 35611637 Free PMC article.
Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy.
Jiang S, Zhang J, Chu L, Chu X, Yang X, Li Y, Guo T, Zhou Y, Xu D, Mao J, Zheng Z, An Y, Sun H, Dong H, Yu S, Ye R, Hu J, Chu Q, Ni J, Zhu Z. Jiang S, et al. Among authors: xu d. Cancers (Basel). 2022 Dec 28;15(1):180. doi: 10.3390/cancers15010180. Cancers (Basel). 2022. PMID: 36612176 Free PMC article.
Brain metastases, patterns of intracranial progression, and the clinical value of upfront cranial radiotherapy in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
Guo T, Chu L, Chu X, Yang X, Li Y, Zhou Y, Xu D, Zhang J, Wang S, Hu J, Chu Q, Moran T, Cho WC, Merrell KW, Rizzo S, Liu Y, Ni J, Zhu Z. Guo T, et al. Among authors: xu d. Transl Lung Cancer Res. 2022 Feb;11(2):173-187. doi: 10.21037/tlcr-22-54. Transl Lung Cancer Res. 2022. PMID: 35280308 Free PMC article.
14 results